Paper9836626
Synthesis of imidazo[1,2-a]pyridines as antiviral agents.
Gueiffier A and 11 others. J Med Chem, 1998. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Synthesis of imidazo[1,2-a]pyridines as antiviral agents. Papers, record 9836626. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9836626
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Imidazoles | Major topic |
| Pyridines | Major topic |
| Animals | |
| Cell Line | |
| Chlorocebus aethiops | |
| Cytomegalovirus | |
| Drug Evaluation, Preclinical | |
| HeLa Cells | |
| Herpesvirus 3, Human | |
| Humans | |
| Inhibitory Concentration 50 | |
| Structure-Activity Relationship | |
| Vero Cells |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796587 | 1,4-Benzo[b]dithiine Derivatives Accessed via Ring Expansion of 1,3-Dithioles. | Molecules | 2026 | https://conductscience.org/library/papers/42796587 | PubMed |
| 42788948 | Development of Dithioacetal-Modified Dihydropyrimidone Derivatives with Potential Anti-Inflammatory Activity for Inflammatory Bowel Disease. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42788948 | PubMed |
| 42395696 | Potassium thiocyanate-promoted four-component alkoxysulfenylation of styrenes with imidazo[1,2-a]pyridines and alcohols. | RSC Adv | 2026 | https://conductscience.org/library/papers/42395696 | PubMed |
| 42038268 | Synthesis, characterization, in vitro and in silico studies of novel lophine clubbed acylthioureas. | RSC Adv | 2026 | https://conductscience.org/library/papers/42038268 | PubMed |
| 41195312 | A copper bromide-decorated magnetic oyster shell biosupport as a sustainable catalyst for heterogeneous synthesis of imidazo[1,2-a]pyridines in glycerol. | Nanoscale Adv | 2025 | https://conductscience.org/library/papers/41195312 | PubMed |
| 40358461 | Visible Light-Mediated Preparation of a Key Intermediate Employed in the Synthesis of Zolpidem and Several Analogs. | Chem Asian J | 2025 | https://conductscience.org/library/papers/40358461 | PubMed |
| 39987147 | Synthesis and biological activities of 3-aminoimidazo[1,2-α]pyridine compounds. | BMC Chem | 2025 | https://conductscience.org/library/papers/39987147 | PubMed |
| 39519692 | Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold. | Molecules | 2024 | https://conductscience.org/library/papers/39519692 | PubMed |
| 38611769 | Novel Thiazole Derivatives Containing Imidazole and Furan Scaffold: Design, Synthesis, Molecular Docking, Antibacterial, and Antioxidant Evaluation. | Molecules | 2024 | https://conductscience.org/library/papers/38611769 | PubMed |
| 37110694 | N-, O- and S-Heterocycles Synthesis in Deep Eutectic Solvents. | Molecules | 2023 | https://conductscience.org/library/papers/37110694 | PubMed |
| 37007054 | Multicomponent synthesis of chromophores - The one-pot approach to functional π-systems. | Front Chem | 2023 | https://conductscience.org/library/papers/37007054 | PubMed |
| 36914696 | Nickel substituted polyoxometalates in layered double hydroxides as metal-based nanomaterial of POM-LDH for green catalysis effects. | Sci Rep | 2023 | https://conductscience.org/library/papers/36914696 | PubMed |
| 36551338 | Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36551338 | PubMed |
| 35529754 | Facile synthesis of novel dithioacetal-naphthalene derivatives as potential activators for plant resistance induction. | RSC Adv | 2019 | https://conductscience.org/library/papers/35529754 | PubMed |
| 35330779 | Synthesis of novel [1,2,4]triazolo[1,5-b][1,2,4,5]tetrazines and investigation of their fungistatic activity. | Beilstein J Org Chem | 2022 | https://conductscience.org/library/papers/35330779 | PubMed |
| 34660956 | Ultrasound-Assisted Iodination of Imidazo[1,2-α]pyridines Via C-H Functionalization Mediated by tert-Butyl Hydroperoxide. | ACS Omega | 2021 | https://conductscience.org/library/papers/34660956 | PubMed |
| 33602331 | Synthesis and therapeutic potential of imidazole containing compounds. | BMC Chem | 2021 | https://conductscience.org/library/papers/33602331 | PubMed |
| 33251420 | Eosin Y-Catalyzed Synthesis of 3-Aminoimidazo[1,2-a]Pyridines via the HAT Process under Visible Light through Formation of the C-N Bond. | ACS Omega | 2020 | https://conductscience.org/library/papers/33251420 | PubMed |
| 31709079 | Crystal structure, DFT calculation, Hirshfeld surface analysis and energy framework study of 6-bromo-2-(4-bromo-phen-yl)imidazo[1,2-a]pyridine. | Acta Crystallogr E Crystallogr Commun | 2019 | https://conductscience.org/library/papers/31709079 | PubMed |
| 31632007 | Pyridine azo disperse dye derivatives and their selenium nanoparticles (SeNPs): synthesis, fastness properties, and antimicrobial evaluations. | Int J Nanomedicine | 2019 | https://conductscience.org/library/papers/31632007 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9836626
GET https://conductscience.org/api/papers/v1/9836626/cited_by?page=2